Notice of Receipt of Complaint; Solicitation of Comments Relating to the Public Interest

CourtInternational Trade Commission
Citation86 FR 61315
Publication Date05 November 2021
Record Number2021-24173
Federal Register / Vol. 86, No. 212 / Friday, November 5, 2021 / Notices
to mitigate for take of the eastern indigo
snake by implementing conservation
measures in the Standard Protection
Measures for the Eastern Indigo Snake
(Service 2013), which primarily focus
on the preservation of the species
during land conversion. The applicant
will also install and maintain silt fence
and chain-link fence along the entire
project boundary and the perimeter of
the project area to deter the species from
entering the roadway and to reduce
wildlife interactions within the
construction zone. In addition to these
measures, the applicant will contribute
$22,820, which is calculated as $163 per
ac of converted habitat, to the Wildlife
Foundation of Florida—Eastern Indigo
Snake Conservation Fund. This
contribution will be used to help ensure
the long-term viability of the species by
maintaining and enhancing existing
populations via habitat conservation,
restoration, and management;
monitoring the status of the extant
populations; identifying and securing
additional eastern indigo snake
populations and habitat; repatriating
populations through reintroductions;
and supporting research that guides
land management and provides
demographic and ecological data. The
Service would require the applicant to
make the contribution to the Fund prior
to engaging in activities associated with
the project.
Public Availability of Comments
Before including your address, phone
number, email address, or other
personal identifying information in your
comment, be aware that your entire
comment, including your personal
identifying information, may be made
available to the public. While you may
request that we withhold your personal
identifying information, we cannot
guarantee that we will be able to do so.
Our Preliminary Determination
The Service has made a preliminary
determination that the applicant’s
project, including land clearing,
infrastructure building, landscaping,
and the proposed mitigation measures,
would individually and cumulatively
have a minor or negligible effect on the
eastern indigo snake and the
environment. Therefore, we have
preliminarily concluded that the ITP for
this project would qualify for categorical
exclusion and the HCP is low effect
under our NEPA regulations at 43 CFR
46.205 and 46.210. A low-effect HCP is
one that would result in (1) minor or
negligible effects on federally listed,
proposed, and candidate species and
their habitats; (2) minor or negligible
effects on other environmental values or
resources; and (3) impacts that, when
considered together with the impacts of
other past, present, and reasonably
foreseeable similarly situated projects,
would not over time result in significant
cumulative effects to environmental
values or resources.
Next Steps
The Service will evaluate the
application and the comments received
to determine whether to issue the
requested permit. We will also conduct
an intra-Service consultation pursuant
to section 7 of the ESA to evaluate the
effects of the proposed take. After
considering the preceding findings, we
will determine whether the permit
issuance criteria of section 10(a)(1)(B) of
the ESA have been met. If met, the
Service will issue ITP number
PER0017213 to Florida Department of
Transportation—Florida’s Turnpike
The Service provides this notice
under section 10(c) of the ESA (16
U.S.C. 1531 et seq.) and its
implementing regulations (50 CFR
17.32) and NEPA (42 U.S.C. 4321 et
seq.) and its implementing regulations
(40 CFR 1506.6 and 43 CFR 46.305).
Robert L. Carey,
Division Manager, Environmental Review,
Florida Ecological Services Field Office.
[FR Doc. 2021–24126 Filed 11–4–21; 8:45 am]
Notice of Receipt of Complaint;
Solicitation of Comments Relating to
the Public Interest
: U.S. International Trade
: Notice.
: Notice is hereby given that
the U.S. International Trade
Commission has received a complaint
entitled Certain Integrated Circuits,
Chipsets, and Electronic Devices, and
Products Containing the Same, DN
3574; the Commission is soliciting
comments on any public interest issues
raised by the complaint or
complainant’s filing pursuant to the
Commission’s Rules of Practice and
: Lisa
R. Barton, Secretary to the Commission,
U.S. International Trade Commission,
500 E Street SW, Washington, DC
20436, telephone (202) 205–2000. The
public version of the complaint can be
accessed on the Commission’s
Electronic Document Information
System (EDIS) at
For help accessing EDIS, please email
General information concerning the
Commission may also be obtained by
accessing its internet server at United
States International Trade Commission
(USITC) at The
public record for this investigation may
be viewed on the Commission’s
Electronic Document Information
System (EDIS) at
Hearing-impaired persons are advised
that information on this matter can be
obtained by contacting the
Commission’s TDD terminal on (202)
: The
Commission has received a complaint
and a submission pursuant to § 210.8(b)
of the Commission’s Rules of Practice
and Procedure filed on behalf of NXP
Semiconductors N.V. and NXP USA,
Inc., on November 1, 2021. The
complaint alleges violations of section
337 of the Tariff Act of 1930 (19 U.S.C.
1337) in the importation into the United
States, the sale for importation, and the
sale within the United States after
importation of certain integrated
circuits, chipsets, and electronic
devices, and products containing the
same. The complainant names as
respondents: MediaTek Inc. of China;
MediaTek USA Inc. of San Jose, CA;, Inc. of Seattle, WA;
Belkin International, Inc. of Playa Vista,
CA; and Linskys USA, Inc. of Irvine,
CA. The complainant requests that the
Commission issue a limited exclusion
order, cease and desist orders, and
impose a bond upon respondents
alleged infringing articles during the 60-
day Presidential review period pursuant
to 19 U.S.C. 1337(j).
Proposed respondents, other
interested parties, and members of the
public are invited to file comments on
any public interest issues raised by the
complaint or § 210.8(b) filing.
Comments should address whether
issuance of the relief specifically
requested by the complainant in this
investigation would affect the public
health and welfare in the United States,
competitive conditions in the United
States economy, the production of like
or directly competitive articles in the
United States, or United States
In particular, the Commission is
interested in comments that:
(i) Explain how the articles
potentially subject to the requested
remedial orders are used in the United
VerDate Sep<11>2014 21:40 Nov 04, 2021 Jkt 256001 PO 00000 Frm 00203 Fmt 4703 Sfmt 4703 E:\FR\FM\05NON1.SGM 05NON1
jspears on DSK121TN23PROD with NOTICES1
Federal Register / Vol. 86, No. 212 / Friday, November 5, 2021 / Notices
Handbook for Electronic Filing Procedures:
All contract personnel will sign appropriate
nondisclosure agreements.
Electronic Document Information System
(ii) identify any public health, safety,
or welfare concerns in the United States
relating to the requested remedial
(iii) identify like or directly
competitive articles that complainant,
its licensees, or third parties make in the
United States which could replace the
subject articles if they were to be
(iv) indicate whether complainant,
complainant’s licensees, and/or third
party suppliers have the capacity to
replace the volume of articles
potentially subject to the requested
exclusion order and/or a cease and
desist order within a commercially
reasonable time; and
(v) explain how the requested
remedial orders would impact United
States consumers.
Written submissions on the public
interest must be filed no later than by
close of business, eight calendar days
after the date of publication of this
notice in the Federal Register. There
will be further opportunities for
comment on the public interest after the
issuance of any final initial
determination in this investigation. Any
written submissions on other issues
must also be filed by no later than the
close of business, eight calendar days
after publication of this notice in the
Federal Register. Complainant may file
replies to any written submissions no
later than three calendar days after the
date on which any initial submissions
were due. No other submissions will be
accepted, unless requested by the
Commission. Any submissions and
replies filed in response to this Notice
are limited to five (5) pages in length,
inclusive of attachments.
Persons filing written submissions
must file the original document
electronically on or before the deadlines
stated above. Submissions should refer
to the docket number (‘‘Docket No.
3574’’) in a prominent place on the
cover page and/or the first page. (See
Handbook for Electronic Filing
Procedures, Electronic Filing
). Please note the
Secretary’s Office will accept only
electronic filings during this time.
Filings must be made through the
Commission’s Electronic Document
Information System (EDIS, https:// No in-person paper-
based filings or paper copies of any
electronic filings will be accepted until
further notice. Persons with questions
regarding filing should contact the
Secretary at
Any person desiring to submit a
document to the Commission in
confidence must request confidential
treatment. All such requests should be
directed to the Secretary to the
Commission and must include a full
statement of the reasons why the
Commission should grant such
treatment. See 19 CFR 201.6. Documents
for which confidential treatment by the
Commission is properly sought will be
treated accordingly. All information,
including confidential business
information and documents for which
confidential treatment is properly
sought, submitted to the Commission for
purposes of this Investigation may be
disclosed to and used: (i) By the
Commission, its employees and Offices,
and contract personnel (a) for
developing or maintaining the records
of this or a related proceeding, or (b) in
internal investigations, audits, reviews,
and evaluations relating to the
programs, personnel, and operations of
the Commission including under 5
U.S.C. Appendix 3; or (ii) by U.S.
government employees and contract
solely for cybersecurity
purposes. All nonconfidential written
submissions will be available for public
inspection at the Office of the Secretary
and on EDIS.
This action is taken under the
authority of section 337 of the Tariff Act
of 1930, as amended (19 U.S.C. 1337),
and of §§ 201.10 and 210.8(c) of the
Commission’s Rules of Practice and
Procedure (19 CFR 201.10, 210.8(c)).
By order of the Commission.
Issued: November 1, 2021.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2021–24173 Filed 11–4–21; 8:45 am]
Drug Enforcement Administration
[Docket No. 20–29]
George Roussis, M.D.; Decision and
On August 10, 2020, the Assistant
Administrator, Diversion Control
Division, Drug Enforcement
Administration (hereinafter, DEA or
Government), issued an Order to Show
Cause to George Roussis, M.D.
(hereinafter, Respondent), of Staten
Island, New York. Order to Show Cause
(hereinafter, OSC), at 1 and 3. The OSC
proposed the denial of Respondent’s
application for DEA Certificate of
Registration, Control No. W20041078C,
because Respondent was excluded from
‘‘participation in Medicare, Medicaid,
and all Federal health care programs
pursuant to section 1320a–7(a) of Title
42’’ and such exclusion ‘‘warrants
denial of [Respondent’s] application for
a DEA registration pursuant to 21 U.S.C.
824(a)(5).’’ Id. at 1–2 (citing Narciso A.
Reyes, M.D., 83 FR 61,678 (2018)).
Specifically, the OSC alleged that, on
or about October 16, 2017, a judgment
was entered against Respondent based
on his conviction on one count of
‘‘Racketeering-Transporting In Aid of
Travel Act-Acceptance of Bribes’’ in
violation of 18 U.S.C. 1952(a)(3) and 2.
Id. at 1 (citing U.S. v. George Roussis,
No. 2:17–CR–00232–SRC–1 (D.N.J. Oct.
16, 2017)). The OSC further alleged that
‘‘[b]ased on [Respondent’s] conviction,
the U.S. Department of Health and
Human Services, Office of [the]
Inspector General (‘‘HHS/OIG’’),
mandatorily excluded [Respondent]
from participation in Medicare,
Medicaid, and all Federal health care
programs pursuant to 42 U.S.C. § 1320a–
7(a).’’ Id. at 2. According to the OSC, the
exclusion was effective on April 19,
2018, and runs for 13 years. Id.
The OSC notified Respondent of the
right to request a hearing on the
allegations or to submit a written
statement, while waiving the right to a
hearing, the procedures for electing each
option, and the consequences for failing
to elect either option. Id. (citing 21 CFR
1301.43). The OSC also notified
Respondent of the opportunity to
submit a corrective action plan. Id. at 2–
3 (citing 21 U.S.C. 824(c)(2)(C)).
By letter dated September 2, 2020,
Respondent timely requested a hearing.
Administrative Law Judge Exhibit
(hereinafter, ALJX) 2. The matter was
placed on the docket of the Office of
Administrative Law Judges and was
assigned to Administrative Law Judge
John J. Mulrooney, II (hereinafter, the
Chief ALJ). On September 11, 2020, the
Chief ALJ issued an Order for
Prehearing Statements. ALJX 3. The
Government timely filed its prehearing
statement on September 25, 2020. ALJX
4. Respondent timely filed his
prehearing statement on October 1,
2020. ALJX 5. On October 19, 2020, the
Chief ALJ issued a prehearing ruling
that, among other things, established the
schedules and procedures for the
remaining prehearing activities and for
the hearing. ALJX 6 (Prehearing Ruling,
at 1–7).
VerDate Sep<11>2014 21:40 Nov 04, 2021 Jkt 256001 PO 00000 Frm 00204 Fmt 4703 Sfmt 4703 E:\FR\FM\05NON1.SGM 05NON1
jspears on DSK121TN23PROD with NOTICES1

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT